跳至主要内容
临床试验/CTRI/2020/08/027270
CTRI/2020/08/027270尚未招募4 期

Study of cisatracurium induced neuromuscular block reversal with different doses of neostigmine and incidence of residual neuromuscular paralysis by using neuromuscular monitor

SMS Medical College0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients willing to participate in the study.
  • 2.Age group between 20 - 40 years.
  • 3.Weight of the patient between 40-70Kgs.
  • 4.Patients belonging to ASA class-I and II

排除标准

  • 1.Obesity (BMI >= 35).
  • 2.Patients with abnormal airway (Mallampati score 3 or more).
  • 3.History of any known neuromuscular disease.
  • 4.Patients with any known cardiac/ respiratory / hepatic or renal disease
  • 5.Patients with known allergy to any drug used in study.
  • 6.Patients taking medication that influences neuromuscular blockade

研究者

相似试验

Study to find incidence of residual neuromuscular... | 临床试验